Abstract Chemoreceptor discharges were recorded from the carotid sinus nerve of the cat in vivo, and their frequency was used as an index of receptor activity. The effects of dopamine on chemoreceptor activity were analyzed in normal and ischemic carotid bodies. Intra-arterial injections of dopamine (DA) induced various patterns of chemoreceptor responses; simple inhibition, inhibition followed by excitation, and simple excitation, depending upon doses and the time interval between two injections. After a large dose of DA, a previous inhibitory response to DA was converted into an excitatory one. Pretreatment of the animal with reserpine (0.1 mg/kg, i.v.) or 5-hydroxydopamine (5 mg/kg, i.v.) also converted the inhibitory response to DA into the excitatory one. After haloperidol (0.1 mg/kg, i.v.), the inhibitory response to DA was completely blocked, and DA induced a dose-dependent increase in chemoreceptor discharges. After 1-hr ischemia of the carotid body, DA induced only the inhibitory response, which was blocked by haloperidol, but did not produce any excitatory responses. Results indicate that DA exerts a self-blocking action on inhibitory dopaminergic receptors which are possibly located on the nerve ending, and that DA, also acting directly on the glomus cell, would produce the chemoreceptor excitation.
animal with specific dopaminergic blocking agents (ZAPATA, 1975; NISHI, 1977; LLADOS and ZAPATA, 1978) , and in other species, dopamine induces excitation of chemoreceptors (JACOBS and COMROE, 1968) . Thus, dopamine exerts dual actions in the carotid body, but the exact site (s) of action of this agent on chemoreceptor elements in the carotid body remains to be elucidated.
We have recently observed that short-term ischemia of the carotid body induces damage to the glomus cells, which leads to dysfunction of these cells without greatly affecting the nerve endings (NISHI et al., 1981) . This provides a preparation where pharmacological characterization of chemoreceptor-stimulating substances can be investigated in respect of the site of action of these substances. Therefore, the present experiments were undertaken to elucidate the actions of dopamine in carotid body chemoreceptors by comparing the effects of this agent in the normal carotid body as against those in the ischemic preparation.
METHODS
The methods used were essentially similar to those described in previous papers (NISHI, 1975; NISHI et al., 1981 
RESULTS
Effects of dopamine on spontaneous activity Chemoreceptor discharges were identified according to the criteria described in the previous paper (NISHI and EYZAGUIRRE, 1971 started to increase with a latent period of about 3 sec after the start of the injection, reached the peak frequency within 10 sec and gradually decreased to the control level. Dose-response curves constructed from discharges in a single chemoreceptor fibre occurring after DA before and after haloperidol are shown in the lower graph of Fig. 5 . In all cases, after haloperidol, the inhibitory effects of DA on chemoreceptor discharges observed during the control period were completely The trace for each record shows chemoreceptor discharge frequency in a few active units. Upper records (A and B) were taken during the control period, while lower records (C and D) were taken 2 hr after 6-hydroxydopamine (6-OHDA) (5 mg/kg, i.v.). Dopamine (DA) injected at arrows. Broken lines indicate the spontaneous discharge rate. 
DISCUSSION
The present results show that 1) exogenously applied DA induces inhibitory and excitatory responses in the carotid body chemoreceptor of the cat in situ, 2) an initial small dose of DA always produces an inhibitory response, but the inhibition is greatly affected by the interval between doses, and furthermore, 3) after a large dose of DA, the inhibitory response to a previous smaller dose of DA is converted to an excitatory one. The inhibitory action of DA on the carotid body chemoreceptor has already been described by many authors. This effect could be due to direct action of DA on the mechanisms responsible for initiation of chemoreceptor discharges (ZAPATA, 1975; NISHI, 1977; LLADOS and ZAPATA, 1978) . Our finding that a large dose of DA blocked the inhibitory response to a subsequently applied smaller dose of DA is consistent with the observations by Zapata (ZAPATA, 1975) that the carotid body superfused in vitro becomes rapidly desensitized to the inhibitory effects of DA. The present results together with previous findings indicate that DA per se possesses the property to occupy the dopaminergic inhibitory receptor for a relatively long period of time and to block the inhibitory action of the subsequently applied smaller doses of DA. This view is supported by the observation that during the initial phase of reserpine treatment, when continuous release of DA from the glomus cell would be expected to occur, the inhibitory effect of DA was also abolished. Furthermore, after treatment with relatively large doses of 6-OHDA, which acts as a dopamine analogue and would be expected to displace DA as well as other catecholamines from the glomus cells, the chemoreceptor depression which followed DA-injections was diminished or suppressed. Thus, the self-blocking action of DA rendered its pharmacological characterization difficult, because it resulted in various patterns of DAresponses amongst the chemoreceptor fibres. With regard to possible sites of action, the present experiments indicate that the inhibitory effects of DA are most likely due to direct actions on the chemoreceptor nerve endings, for the following reasons : 1) DA induced inhibitory effects on chemoreceptor discharge in the 1-hr ischemic carotid body, in which the nerve endings would remain relatively intact, but the glomus cells would presumably have undergone degeneration, and 2) the inhibition of chemoreceptor discharge occurred within 0.5-1 sec after the start of the DA injection, which is characteristic of substances that act directly on sensory nerve endings (NISHI and EYZAGUIRRE, 1971; NISHI, 1975) .
After blockade of the inhibitory receptors by DA itself or by other dopaminergic blocking agents, DA induced an increase in chemoreceptor discharges. In the experiments in vivo, in which effects of DA upon carotid body vessels cannot be eliminated, there is a possibility that the present results could have been mainly due to the vascular effects of the agent, since the carotid body chemoreceptors are very sensitive to changes in blood flow within the carotid body (HOWE and NEIL, 1972) . However, this view cannot be supported by the observation made by Zapata that the inhibitory response to DA was converted into an excitatory one after treatment of the carotid body with dopaminergic blocking agents in the carotid body which were superfused in vitro, where the vascular effect of the agent can be disregarded (ZAPATA, 1975) . Therefore, it is likely that these agents block dopaminergic inhibitory receptors, but leave dopaminergic excitatory receptors intact and responsive. A question arises as to whether the excitatory receptors are located in the same nerve ending or in other chemoreceptor elements, such as the glomus cell. In this respect, the present findings were substantial; there was no excitatory response to DA after haloperidol in the 1-hr ischemic carotid body. If one assumes that exogenously-applied DA would also act directly on the glomus cell, which in turn would excite the post-synaptic element in the carotid body through a mechanism which at present is unknown, then abolition of the excitatory response to DA after haloperidol would be due to dysfunction of the glomus cell after 1-hr ischemia of the carotid body.
